<i>LRRK2</i> G2019S mutation suppresses differentiation of Th9 and Treg cells via JAK/STAT3
Ningbo Zheng(Research Network (United States)), Weiyi Peng(University of Houston)
Cited by 1
Related Papers
Integrating genome-wide CRISPR immune screen with multi-omic clinical data reveals distinct classes of tumor intrinsic immune regulators
|Journal for ImmunoTherapy of Cancer|2021|47
Inhibiting Type I Arginine Methyltransferase Activity Promotes T Cell–Mediated Antitumor Immune Responses
|Cancer Immunology Research|2022|31
MTA-cooperative PRMT5 inhibitors enhance T cell-mediated antitumor activity in MTAP-loss tumors
|Journal for ImmunoTherapy of Cancer|2024|18